%0 Journal Article
%T Paraneoplastic Glomerular Diseases.
%A Muthukumaran A
%A Wanchoo R
%A Seshan SV
%A Gudsoorkar P
%J Adv Kidney Dis Health
%V 31
%N 4
%D 2024 Jul
%M 39084760
暂无%R 10.1053/j.akdh.2024.04.008
%X Paraneoplastic glomerular disease (PGD) develops from tumor cell products, leading to renal dysfunction. Unlike direct tumor effects, PGD illustrates the complex association between cancer and diverse clinical presentations and outcomes. Initially detected in a Hodgkin's disease patient, current research has defined diagnostic criteria based on PGD symptoms and cancer progression. PGDs, although rare (found in <1% of adult cancer patients with overt renal manifestations), are crucial, as they can signal cancer onset and frequently resist standard glomerulonephritis treatments. The emerging field of onconephrology studies this relationship between kidney disorders and cancers. The exact cause of many PGD cases remains unknown. This review examines PGDs, their clinicopathological features, related cancers, and mechanisms, emphasizing the need for early diagnosis and tailored treatment for kidney disease and linked cancer.